Depression and complementary medicines
Around one in 16 Australians will suffer from depression at some time during their life.1,2 What evidence is there that complementary medicines such as S-Adenosyl-L-methionine...
PSA: embed pharmacists to reduce medicine harm in aged care
PSA has called for a national program that embeds pharmacists in all aged care facilities in its submission to the Royal Commission into Aged...
Q&A: ‘I’m going overseas tomorrow . . . can you witness...
While pharmacists are now (very) familiar with rapid antigen tests (RATs) for COVID-19 testing, the practice of observed RATs for the purpose of international...
Pharmacovigilance and therapeutic risk management across the medicine lifecycle
Pharmacists play a key role in pharmacovigilance, monitoring medicine safety beyond clinical trials and into real-world patient populations.
Management of apathy in patients with Alzheimer’s disease
People diagnosed with Alzheimer’s disease often experience symptoms of apathy, which can be treated by pharmacological and behavioural interventions.
The purpose of this evidence...
What’s pharmacists’ role in detecting and preventing cardiovascular disease?
Cardiovascular disease is increasingly preventable and treatable – but too many Australians are still being missed. From identifying hypertension earlier to navigating new medicines, community pharmacists can help to improve cardiovascular care.
